GBA1 and Parkinson disease: In addition to a significantly large reduction of lysosomal GCase activity observed in tissues derived from PD patients harboring GBA mutations [8, 10, 15], intermediate deficits in this enzyme activity have also been observed in blood, CSF, and post-mortem brain tissue from sporadic PD patients [4, 8, 10, 13, 15].